论文部分内容阅读
肝纤维化是多种慢性肝病所共有的病理特征,是进一步向肝硬化发展的主要中间环节,它的防治是当今肝病治疗的难点之一,临床上缺乏有效的治疗手段。近年来,大量的研究对肝纤维化的发生机制有了不少新的认识,推动了抗肝纤维化药物的研发。
Liver fibrosis is a common pathological feature of many chronic liver diseases and is the main intermediate link to further develop cirrhosis. Prevention and treatment of liver fibrosis is one of the difficulties in the treatment of liver diseases. There is a lack of effective treatment in clinical practice. In recent years, a large number of studies have made a lot of new understanding of the mechanism of liver fibrosis and promoted the development of anti-hepatic fibrosis drugs.